• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,617.37 93.11
( 0.13%)
Global Indices
Nasdaq
50,812.84 -74.94
(-0.15%)
Dow Jones
7,426.81 22.07
(0.30%)
Hang Seng
63,697.20 -2,890.92
(-4.34%)
Nikkei 225
10,368.25 0.20
(0.00%)
Forex
USD-INR
95.22 -0.51
(-0.53%)
EUR-INR
109.67 -1.54
(-1.39%)
GBP-INR
126.98 -1.60
(-1.25%)
JPY-INR
0.59 0.00
(-0.77%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
514.6538079
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
38.14
1266.71
EPS(TTM)
Face Value()
Div & Yield %
60.24
10
0
 

amaryug finance ltd
Veedol Corp gains after Q3 PAT climbs 17% YoY to Rs 43 cr
Feb 03,2026
Profit before tax (PBT) jumped 50.32% YoY to Rs 55.36 crore during the quarter.

Total expenses rose 9.53% to Rs 495.28 crore during the quarter, compared with Rs 452.17 crore recorded in Q3 FY25. Cost of material consumed stood at Rs 290.55 crore (up 12.92% YoY), employee benefit expenses stood at Rs 41.77 crore (up 10.88% YoY) and franchisee fees stood at Rs 68.16 crore (up 1.64% YoY) during the period under review.

Meanwhile, the company’s board declared dividend of Rs 14 per share for FY26. The record date has been set as Friday, 6 February 2026. The dividend will be paid within 30 days of the date of declaration.

Veedol Corporation engaged in the business of manufacturing and marketing of lubricants.